Lysosomal Storage Diseases. For Better or Worse: Adapting to Defective Lysosomal Glycosphingolipid Breakdown

Detalhes bibliográficos
Autor(a) principal: Aerts, Johannes M.
Data de Publicação: 2017
Outros Autores: Ferraz, Maria J., Mirzaian, Mina, Gaspar, Paulo, Oussoren, Saskia V., Wisse, Patrick, Kuo, Chi-Lin, Lelieveld, Lindsey T., Kytidou, Kassiani, Hazeu, Marc D., Boer, Daphne E.C., Meijer, Rianne, van der Lienden, Martijn J.C., Chao, Daniela H.M., Gabriel, Tanit L., Aten, Jan, Overkleeft, Herman S., van Eijk, Marco, Boot, Rolf G., Marques, André R.A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.18/5477
Resumo: The cellular recycling of glycosphingolipids (GSLs) is mediated by specific lysosomal glycosidases. Inherited deficiencies in these enzymes cause lysosomal storage disorders. Some of the common disorders are Gaucher disease (GD) and Fabry disease (FD) resulting from the defects in lysosomal glucocerebrosidase (GBA) degrading glucosylceramide and α‐galactosidase A (GLA) degrading globotriaosylceramide. Here, GSL accumulation in tissues slows down with age despite ongoing lysosomal turnover of endogenous and endocytosed GSLs. Biochemical adaptations might explain this phenomenon. One crucial adaptation is the deacylation of accumulating GSLs in lysosomes by acid ceramidase. The soluble bases glucosylsphingosine in GD and globotriaosylsphingosine in FD are capable of leaving lysosomes and cells. In the case of GD, a further adaptation involves the cytosol‐faced enzyme GBA2. This enzyme allows extra‐lysosomal degradation of GlcCer while possibly generating glucosylated cholesterol. The beneficial and harmful effects of these adaptations are discussed.
id RCAP_9d8683631e1c63bf55e7832b407c79b7
oai_identifier_str oai:repositorio.insa.pt:10400.18/5477
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Lysosomal Storage Diseases. For Better or Worse: Adapting to Defective Lysosomal Glycosphingolipid BreakdownLysosomeLysosomal Storage DisordersGlycosphingolipidGlucocerebrosidaseGlucosylsphingosineGaucher DiseaseFabry DseaseLysoGb3Doenças GenéticasThe cellular recycling of glycosphingolipids (GSLs) is mediated by specific lysosomal glycosidases. Inherited deficiencies in these enzymes cause lysosomal storage disorders. Some of the common disorders are Gaucher disease (GD) and Fabry disease (FD) resulting from the defects in lysosomal glucocerebrosidase (GBA) degrading glucosylceramide and α‐galactosidase A (GLA) degrading globotriaosylceramide. Here, GSL accumulation in tissues slows down with age despite ongoing lysosomal turnover of endogenous and endocytosed GSLs. Biochemical adaptations might explain this phenomenon. One crucial adaptation is the deacylation of accumulating GSLs in lysosomes by acid ceramidase. The soluble bases glucosylsphingosine in GD and globotriaosylsphingosine in FD are capable of leaving lysosomes and cells. In the case of GD, a further adaptation involves the cytosol‐faced enzyme GBA2. This enzyme allows extra‐lysosomal degradation of GlcCer while possibly generating glucosylated cholesterol. The beneficial and harmful effects of these adaptations are discussed.Key concepts: Glycosphingolipids (GSLs) are membrane constituents composed of a ceramide with one or more sugars. The simplest GSL is glucosylceramide (GlcCer). Ongoing recycling of GSLs in cells includes lysosomal degradation by the sequential action of glycosidases and acid ceramidase. Deficiency of lysosomal glycosidase leads to lysosomal storage diseases caused by accumulation of the corresponding substrate in lysosomes. The most common glycosphingolipidoses are Gaucher disease (GD) and Fabry disease (FD). GD is an autosomal recessive disorder caused by deficient activity of the lysosomal enzyme acid β‐glucosidase (glucocerebrosidase; GBA) resulting in lysosomal accumulation of GlcCer. FD is an X‐linked disorder caused by deficient activity of the lysosomal enzyme α‐galactosidase A (GLA) resulting in lysosomal accumulation of globotriaosylceramide (Gb3). Accumulation of storage lipids during GBA and GLA tends to slow down with age, likely partly due to poorly appreciated biochemical adaptations. Active conversion of accumulating GlcCer in lysosomes of GBA‐deficient cells is mediated by acid ceramidase, resulting in the formation of water‐soluble glucosylsphingosine (GlcSph). Likewise, globotriaosylsphingosine (lysoGb3) is formed from accumulating in lysosomes of GLA‐deficient cells. Elevated plasma GlcSph and lysoGb3 levels can be sensitively measured LC–MS and may assist in diagnosing and monitoring of the disease and response to treatment in GD and FD patients, respectively. Increased GlcSph level in GD patients acts as an autoantigen, causing ongoing B‐cell proliferation, leading to multiple myeloma. Increased lysoGb3 level in FD patients is thought to cause damage to nociceptive neurons and podocytes, thus contributing to pain and renal failure. In GD, the cytosol‐faced enzyme β‐glucosidase GBA2 allows degradation of GlcCer outside lysosomes. Through transglycosylation, GBA2 may generate glucosylcholesterol and ceramide from GlcCer and cholesterol. The toxic effects of secondary metabolites such as glycosphingoid bases (GlcSph in GD and lysoGb3 in FD) and glucosylated metabolites (GlcChol in GD) warrant further investigations.John Wiley & Sons, LtdRepositório Científico do Instituto Nacional de SaúdeAerts, Johannes M.Ferraz, Maria J.Mirzaian, MinaGaspar, PauloOussoren, Saskia V.Wisse, PatrickKuo, Chi-LinLelieveld, Lindsey T.Kytidou, KassianiHazeu, Marc D.Boer, Daphne E.C.Meijer, Riannevan der Lienden, Martijn J.C.Chao, Daniela H.M.Gabriel, Tanit L.Aten, JanOverkleeft, Herman S.van Eijk, MarcoBoot, Rolf G.Marques, André R.A.2018-03-27T14:58:46Z2017-102017-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.18/5477engeLS: Essential for Life Science (eLS, 1)978047001617610.1002/9780470015902.a0027592info:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-20T15:40:54Zoai:repositorio.insa.pt:10400.18/5477Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:40:11.208215Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Lysosomal Storage Diseases. For Better or Worse: Adapting to Defective Lysosomal Glycosphingolipid Breakdown
title Lysosomal Storage Diseases. For Better or Worse: Adapting to Defective Lysosomal Glycosphingolipid Breakdown
spellingShingle Lysosomal Storage Diseases. For Better or Worse: Adapting to Defective Lysosomal Glycosphingolipid Breakdown
Aerts, Johannes M.
Lysosome
Lysosomal Storage Disorders
Glycosphingolipid
Glucocerebrosidase
Glucosylsphingosine
Gaucher Disease
Fabry Dsease
LysoGb3
Doenças Genéticas
title_short Lysosomal Storage Diseases. For Better or Worse: Adapting to Defective Lysosomal Glycosphingolipid Breakdown
title_full Lysosomal Storage Diseases. For Better or Worse: Adapting to Defective Lysosomal Glycosphingolipid Breakdown
title_fullStr Lysosomal Storage Diseases. For Better or Worse: Adapting to Defective Lysosomal Glycosphingolipid Breakdown
title_full_unstemmed Lysosomal Storage Diseases. For Better or Worse: Adapting to Defective Lysosomal Glycosphingolipid Breakdown
title_sort Lysosomal Storage Diseases. For Better or Worse: Adapting to Defective Lysosomal Glycosphingolipid Breakdown
author Aerts, Johannes M.
author_facet Aerts, Johannes M.
Ferraz, Maria J.
Mirzaian, Mina
Gaspar, Paulo
Oussoren, Saskia V.
Wisse, Patrick
Kuo, Chi-Lin
Lelieveld, Lindsey T.
Kytidou, Kassiani
Hazeu, Marc D.
Boer, Daphne E.C.
Meijer, Rianne
van der Lienden, Martijn J.C.
Chao, Daniela H.M.
Gabriel, Tanit L.
Aten, Jan
Overkleeft, Herman S.
van Eijk, Marco
Boot, Rolf G.
Marques, André R.A.
author_role author
author2 Ferraz, Maria J.
Mirzaian, Mina
Gaspar, Paulo
Oussoren, Saskia V.
Wisse, Patrick
Kuo, Chi-Lin
Lelieveld, Lindsey T.
Kytidou, Kassiani
Hazeu, Marc D.
Boer, Daphne E.C.
Meijer, Rianne
van der Lienden, Martijn J.C.
Chao, Daniela H.M.
Gabriel, Tanit L.
Aten, Jan
Overkleeft, Herman S.
van Eijk, Marco
Boot, Rolf G.
Marques, André R.A.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Nacional de Saúde
dc.contributor.author.fl_str_mv Aerts, Johannes M.
Ferraz, Maria J.
Mirzaian, Mina
Gaspar, Paulo
Oussoren, Saskia V.
Wisse, Patrick
Kuo, Chi-Lin
Lelieveld, Lindsey T.
Kytidou, Kassiani
Hazeu, Marc D.
Boer, Daphne E.C.
Meijer, Rianne
van der Lienden, Martijn J.C.
Chao, Daniela H.M.
Gabriel, Tanit L.
Aten, Jan
Overkleeft, Herman S.
van Eijk, Marco
Boot, Rolf G.
Marques, André R.A.
dc.subject.por.fl_str_mv Lysosome
Lysosomal Storage Disorders
Glycosphingolipid
Glucocerebrosidase
Glucosylsphingosine
Gaucher Disease
Fabry Dsease
LysoGb3
Doenças Genéticas
topic Lysosome
Lysosomal Storage Disorders
Glycosphingolipid
Glucocerebrosidase
Glucosylsphingosine
Gaucher Disease
Fabry Dsease
LysoGb3
Doenças Genéticas
description The cellular recycling of glycosphingolipids (GSLs) is mediated by specific lysosomal glycosidases. Inherited deficiencies in these enzymes cause lysosomal storage disorders. Some of the common disorders are Gaucher disease (GD) and Fabry disease (FD) resulting from the defects in lysosomal glucocerebrosidase (GBA) degrading glucosylceramide and α‐galactosidase A (GLA) degrading globotriaosylceramide. Here, GSL accumulation in tissues slows down with age despite ongoing lysosomal turnover of endogenous and endocytosed GSLs. Biochemical adaptations might explain this phenomenon. One crucial adaptation is the deacylation of accumulating GSLs in lysosomes by acid ceramidase. The soluble bases glucosylsphingosine in GD and globotriaosylsphingosine in FD are capable of leaving lysosomes and cells. In the case of GD, a further adaptation involves the cytosol‐faced enzyme GBA2. This enzyme allows extra‐lysosomal degradation of GlcCer while possibly generating glucosylated cholesterol. The beneficial and harmful effects of these adaptations are discussed.
publishDate 2017
dc.date.none.fl_str_mv 2017-10
2017-10-01T00:00:00Z
2018-03-27T14:58:46Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.18/5477
url http://hdl.handle.net/10400.18/5477
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv eLS: Essential for Life Science (eLS, 1)
9780470016176
10.1002/9780470015902.a0027592
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv John Wiley & Sons, Ltd
publisher.none.fl_str_mv John Wiley & Sons, Ltd
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132143273639936